Envoy Medical, Inc. (COCH) vs INmune Bio, Inc. (INMB)
A side-by-side comparison of Envoy Medical, Inc. and INmune Bio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
COCH
Envoy Medical, Inc.
$0.67HealthcareDelayed quote: Oct 6, 2026, 12:44 PM EDT
INMB
INmune Bio, Inc.
$1.89HealthcareDelayed quote: Oct 6, 2026, 12:58 PM EDT
Total return — COCH vs INMB
growth of $100 · dividends reinvested · last 5yCOCH -93.3% (-41.8%/yr)INMB -83.7% (-30.4%/yr)INMB compounded faster over this window
COCH INMB
COCH vs INMB: by the numbers
- •COCH is the larger company ($51M vs $50M market cap).
- •Both run net losses; COCH's is the smaller (-11304.83% vs -91866.00% net margin).
Metrics side by side
Valuation
| Metric | COCH | INMB |
|---|---|---|
| P/S ratio | 247.99 | N/A |
| P/B ratio | 15.54 | 2.47 |
Profitability
| Metric | COCH | INMB |
|---|---|---|
| Gross margin | -262.66% | 100.00% |
| Operating margin | -9240.66% | -61738.00% |
| Net margin | -11304.83% | -91866.00% |
| ROE | -708.48% | -90.44% |
| ROIC | -208.76% | -96.37% |
Growth (annualized)
| Metric | COCH | INMB |
|---|---|---|
| Total return CAGR (5Y) | -41.73% | -36.88% |
Frequently asked
- How have COCH and INMB total returns compared?
- Over the past 5 years, COCH delivered -41.73% and INMB delivered -36.88% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.